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Abstract 11 
In this paper, the mass transfer coefficient (permeability) of boundary layers containing motile 12 
cilia is investigated by means of discrete multi-physics. The idea is to understand the main 13 
mechanisms of mass transport occurring in a ciliated-layer; one specific application being 14 
inhaled drugs in the respiratory epithelium. The effect of drug diffusivity, cilia beat frequency 15 
and cilia flexibility is studied. Our results show the existence of three mass transfer regimes. 16 
A low frequency regime, which we called shielding regime, where the presence of the cilia 17 
hinders mass transport; an intermediate frequency regime, which we have called diffusive 18 
regime, where diffusion is the controlling mechanism; and a high frequency regime, which we 19 
have called convective regime, where the degree of bending of the cilia seems to be the most 20 
important factor controlling mass transfer in the ciliated-layer. Since the flexibility of the cilia 21 
2 
 
and the frequency of the beat changes with age and health conditions, the knowledge of these 22 
three regimes allows prediction of how mass transfer varies with these factors.  23 
Keywords: Discrete Multi-Physics, Smoothed Particle Hydrodynamics, Mass-Spring Model, 24 
cilia, diffusivity, mass transfer 25 
1. Introduction 26 
Motile cilia are hair-like structures present on the surface of a variety of cells. They are found 27 
in large numbers in the human body and beat in coordinated waves to perform a number of 28 
different functions. For instance, in the conducting and central airways of the lungs, cilia are 29 
surrounded by mucus that traps particulate materials and pathogens. The coordinated motion 30 
of the cilia propels these materials towards the pharynx where they are swallowed or expelled 31 
via coughing, a phenomenon known as mucociliary clearance or mucociliary escalator [1]. 32 
Mathematical modelling of this phenomenon has attracted the interest of various researchers 33 
in material, biological and pharmaceutical sciences. The main motivation is to understand the 34 
factors controlling the effectiveness of mucociliary clearance since this is important in the 35 
context of environmental exposure (see [2] for a detailed review). [3] introduced an analytical 36 
model of a mucus layer with cilia motion. Their findings suggested that the mucus flow in 37 
contact with the airway is governed by a viscosity gradient in the mucus layer, but in this 38 
work, the cilia were only considered as rigid rods. Later, [4] implemented a more realistic 39 
cilia motion model including effective and recovery stroke in a two layers system. The 40 
outcomes highlighted the role of the cilia penetration (in the mucus layer) on the mucus 41 
transport effectiveness. At the beginning of the new century, [5] focused their researches on 42 
the mucus draining in an idealised rigid bronchial tree with an air flow effect. Their model 43 
showed the viscosity-dependence of the mucus transport as well as the important role of the 44 
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geometry. The emergence of the Immersed Boundary Method (IBM) has allowed a significant 45 
enhancement in mucociliary clearance modelling. [6] studied the effects of the velocity, the 46 
viscosity, the beat cilia frequency, the number of cilia and the depth of the periciliary layer. 47 
The main results showed that (i) the velocity of the periciliary fluid is linearly proportional to 48 
the cilia beat frequency, (ii) the mucus viscosity plays a little role on the mucus flow rate 49 
contrary to the number of cilium which increases the mucus transport, and (iii) a minimum 50 
depth of periciliary layer is needed to generate a mucociliary transport. [7] extended the two-51 
dimensional [6] model to a three-dimensional representation and thus were able to capture the 52 
cilia motion in the normal direction; they confirmed the previous results. Additionally, the 53 
same authors in another publication [8], focused on cilia dysfunction and malformation. They 54 
emphasized the negative effects of too elastic and too rigid cilia beat patterns on the mucus 55 
transport. Then, a method coupling IBM with a lattice Boltzmann method was used by [9] to 56 
implement an Oldroyd-B model and to simulate a viscoelastic fluid. They found that an 57 
increase of the mucus viscosity accelerates the movement of mucus layer. [10] with a penalty 58 
technique, also concentrated their researches on genetic cilia diseases and defective mucus 59 
clearance using a non-Newtonian model. They correlated, in the case of cystic fibrosis, mucus 60 
velocity and rheology with a mucus maturation model and highlighted that shear-thinning 61 
mucus can accentuate agglomeration phenomena in regions with ineffective clearance. Most 62 
of the previous studies have focused on the altered effectiveness of mucociliary clearance 63 
under disease states, for example in primary or acquired ciliary dyskinesia. Here, we also take 64 
a look how impairments to the ciliary function can modify the speed with which pollutants, 65 
irritants and toxic agents can reach the airway epithelium.    66 
While mucociliary escalator is one of the major defence mechanisms protecting the lungs, it 67 
has important implications in pulmonary drug delivery. In the case of inhaled aerosolized 68 
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medicines, mucociliary clearance competes with the particle dissolution and absorption that 69 
eventually determines the lung bioavailability of the inhaled drugs [11]. Smaller particles 70 
trapped in the mucus layer progressively dissolve and diffuse towards the epithelium and the 71 
drug gets absorbed (Fig. 1a). On the other hand, larger or slowly dissolving particles are 72 
partly cleared by the ciliary action, thus reducing the amount of drug absorbed (Fig. 1b). 73 
Mucociliary clearance concerns the mass transfer of particles trapped in the mucus layer to 74 
the pharynx for clearance, whilst the drug absorption depends on the diffusion of particles 75 
towards the epithelium through the mucus and the ciliated-layer. The role that the cilia beat 76 
pattern plays as part of the mucociliary clearance mechanism has been studied in the past.  77 
While the cilia beat is also likely to affect mass transfer, to the best of our knowledge, it has 78 
received no attention in the literature from this perspective. 79 
 80 
Fig. 1. Drug absorption (a) versus mucociliary clearance (b). 81 
In this work, we use a modelling technique called discrete multi-physics [12-17] to investigate 82 
how the motion of the cilia affects mass transfer conditions in the ciliated-layer. By means of 83 
discrete multi-physics, the following research questions are addressed. Does the presence of 84 
the cilia enhance or hinder the mass transfer in the ciliated layer? For example, it is known 85 
that smoking, age, and health conditions affect the frequency of the cilia beat [18]. Thus, it is 86 
of interest to understand how drug absorption is sensitive to the frequency of the beat. Finally, 87 
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does the flexibility of the cilia, which also depends on age and health conditions [19], play a 88 
role too? 89 
Answering these questions can provide insights not only to the development of inhalation 90 
medicines, or to the dynamics of harmful chemicals during environmental exposure, , but also 91 
the design of artificial cilia needed for lab-on-a-chip or organ-on-a-chip applications [20]. 92 
2. Preliminary considerations and background 93 
2.1 Cilia beat 94 
In the past, several studies [21-27] have investigated the cilia motion in the respiratory 95 
epithelium. The results are not always fully consistent with each other (e.g. Fig. 2), but in 96 
general, the cilia motion is divided into two phases: an ‘effective stroke’, in which the cilia 97 
move forward and propel the mucus layer in the same direction; and a ‘recovery stroke’, in 98 
which the cilia return to their initial position. 99 
 100 
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Fig. 2. Cilium’s motion according to (a) Sanderson and Sleigh [22] and (b) Aiello and Sleigh 101 
[21] and (c) metachronal wave. 102 
Moreover, the movement of each cilium (Fig. 2) is coordinated with that of the others 103 
producing a wave-like overall motion known as metachronal wave. A variety of cilia beat 104 
frequencies in the range between 3 and 20 Hz have been observed in the respiratory 105 
epithelium, with the frequency being a function of temperature, age and health conditions [25-106 
27]. Artificial cilia used in lab-on-a-chip applications, on the other hand, can reach higher 107 
frequencies in the order of 50 Hz [28]. 108 
2.2 Membrane permeability and mass transfer 109 
In general, the rate of absorption of a certain drug into the body depends on the permeability 110 
Pme [m s
-1
] of the cellular membrane to that specific drug. In experiments, the drug’s flux 111 
through the membrane J [kg m
-2
 s
-1
] is measured and the permeability calculated from 112 
,ccPJ me )( 21 −=  (1) 
where c2 − c1 [kg m
-3
] is the difference of drug’s concentration across the membrane (Fig. 113 
3a). 114 
If before permeating the membrane, the drug diffuses through an additional mass transfer 115 
resistance (e.g. the layer of mucus), the total permeability PTOT of the mucus + the membrane 116 
layer is given by  117 
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,
PPP mumeTOT
111
+=  (2) 
where Pmu is the drug’s permeability of the mucus layer. 118 
 119 
Fig. 3. Permeability through a membrane (epithelium), (b) permeability through 120 
membrane + mucus, (c) permeability through membrane + mucus + ciliated-layer. 121 
 In the respiratory epithelium, between the mucus layer and the membrane, there is a third 122 
layer, the periciliary layer (PCL), where a low-viscosity fluid is agitated by motile cilia. The 123 
overall permeability of the mucus + ciliated + membrane layer is, therefore, 124 
,
PPPP pclmumeTOT
1111
++=  (3) 
where Ppcl is the permeability of the ciliated−layer.  125 
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Permeability is the term mostly used in biology and medicine; in physics and engineering, it is 126 
often replaced by the molecular diffusivity D [m
2
 s
-1
], which is linked to permeability by the 127 
relation 128 
,
D
P
δ
=  (4) 
where δ [m] is the thickness of the layer where the drug diffuses. There is, however, a 129 
fundamental difference between mass transfer in the membrane or in the mucus layer, and in 130 
the PCL. The diffusivities Dme (membrane) and Dmu (mucus) originate from 131 
hydrodynamically static layers and only depend on the molecular interaction between the 132 
diffusing drug and the diffusive medium; they can be measured from standard experiments, 133 
which do not depend on hydrodynamics. The PCL, on the other hand, is hydrodynamically 134 
active since the motion of the cilia generates recirculation regions where mass transfer 135 
depends on convection rather than diffusion. Under certain conditions, discussed in Section 136 
3.2, however, the dynamics can be considered pseudo-diffusive and an apparent diffusivity 137 
coefficient Dpcl can be used to model the mass transport in the ciliated-layer. This means that 138 
Eq. (3) can be rewritten as 139 
,
DDDD pcl
pcl
mu
mu
me
me
TOT
TOT
δδδδ
++=  (5) 
While Dme and Dmu are real diffusivities, which are constant for a given drug, Dpcl is a 140 
pseudo-diffusivity, which also depends on the motion of the cilia. The goal of this paper is to 141 
determine how the pseudo-diffusivity Dpcl is affected by the three parameters: (i) the 142 
molecular diffusivity D of the drug in the periciliary fluid, (ii) the frequency f [s
-1
] of the cilia 143 
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beat, and (iii) the flexibility of the cilia measured as bending length s [m] covered by the cilia 144 
during bending. 145 
 146 
2.3 Soluble versus insoluble particles 147 
Inhalation devices deliver medicines to the airways in the form of fine solid particles 148 
(typically in the range of 2 to 6 µm) or liquid droplets (aerosols). Particles that dissolve in the 149 
mucus gradually diffuse and reach the epithelium (Section 2.2). As discussed earlier, the fate 150 
of insoluble particles depends on their size. Particles larger than 6 µm are trapped in the 151 
mucus layer and eliminated by mucociliary clearance. Particles smaller than 6 µm, instead, 152 
can penetrate the mucus layer and diffuse similarly to molecules of soluble drugs. Their 153 
diffusivity DB is the result of Brownian motion and can be calculated according to the Stokes-154 
Einstein relation 155 
,
a
Tk
D BB πµ3
=  (6) 
where kB is the Boltzmann constant [kg m
2
 s
-2
 K
-1
], T [K] the temperature, µ [Pa s] the 156 
viscosity of the fluid and a [m] the diameter of the particle. Based on Eq. (6), in our analysis, 157 
we can treat soluble particles and small insoluble particles in the same way. The only 158 
difference being that the latter case requires the Brownian diffusivity DB instead of the 159 
molecular diffusivity D. 160 
3. Modelling Approach 161 
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To determine how the pseudo-diffusivity Dpcl depends on the molecular diffusivity, the beat 162 
frequency and the flexibility of the cilia, we use a computational approach called Discrete 163 
Multi-Physics (DMP) that links various discrete (i.e. particle based) modelling techniques in 164 
order to reach results not attainable with each technique separately. This method has been 165 
successfully tested for both solid-liquid flows [12-14] and fluid-structure interaction [15-17]. 166 
In this study, Smoothed Particle Hydrodynamics (SPH) is used to simulate the fluid, and the 167 
Mass-Spring Model (MSM) to simulate the membrane. A brief introduction to SPH and MSM 168 
is given in Appendix A and more details can be found in the aforementioned publications. 169 
3.1 Geometry 170 
Many modelling works on mucociliary clearance follows a 2D representation of the ciliated-171 
layer (see [2] for a review); in this study, we also follow this approach. The computational 172 
domain (Fig. 4a) is divided into four regions: the mucus, the PCL, the cilia and the membrane. 173 
SPH particles are used to model the mucus and the PCL, MSM particles are used to model the 174 
cilia, while static SPH particles are used for the membrane. In the following, we refer to the 175 
particles used for the cilia as cilia-particles, to the particles used to model the mucus layer as 176 
mucus-particles, and so on. The computational box is shown in Fig. 4b. There are 36 cilia 177 
with length Lpcl = 5 µm each, the distance between cilia is l = 0.5 µm and the total length of 178 
the section investigated is W = 20 µm; since periodic boundary conditions in the x-direction 179 
are considered, each particle whose position is x < 0 or x > W is reintroduced on the other side 180 
of the computational box. The actual computational domain, therefore, is defined as an 181 
infinite replica in the x-direction of the computational box illustrated in Fig. 4b. The thickness 182 
of the mucus layer in the simulation is Hmu 2 µm, which is lower than the actual mucus layer 183 
(typically 3-5 µm [29]). In this study, this is not a limitation since we are mostly interested in 184 
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the mass transport in the PCL and the mucus layer is only needed to determine the 185 
concentration at the boundary conditions. A smaller mucus layer requires less computational 186 
particles and allows faster simulations. 187 
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 188 
Fig. 4. The geometry of the PCL (a) and the computational box used in the simulations (b). 189 
13 
 
Modelling the metachronal wave of the cilia turned out to be a challenging task. If only a few 190 
cilia are considered, a series of time-dependent forces can be imposed to the cilia-particles 191 
resulting in an approximately correct bending and straitening motion of each cilium. When 192 
the number of cilia is above four or five, however, the interaction with the fluid produces a 193 
gradual loss of coordination among the cilia that, as time progresses, breaks the metachronal 194 
rhythm. We have tried a number of different strategies (based on forces applied to the cilia 195 
computational particles) to overcome this problem; the best solution we found consists of 196 
using a fifth type of ‘ghost’ particles that only interact, by means of a repulsive force (see 197 
Appendix A), with the cilia. These particles are arranged in a parabolic shape that moves 198 
horizontally (see Fig. 4b). The PCL fluid and the mucus do not feel the presence of these 199 
‘ghost’ particles (no interaction forces), but if the parabola comes into contact with a cilium, 200 
the cilium bends and follows the outline of the parabola (interaction forces). When the 201 
parabola moves away, the cilium gradually recovers its original shape. In this way, the 202 
coordination of the metachronal wave is maintained for the entire duration of the simulation 203 
and the shapes obtained are consistent with those observed in the literature (Fig. 2). Given the 204 
periodic boundary conditions explained above, when the parabola exits the domain from x = 205 
W, it is re-introduced at x = 0. The velocity of the parabola vP and the length of the domain W 206 
determine the frequency of the beat (i.e. f = vP/W). The ‘ghost’ parabola is also used to 207 
investigate the effect of the flexibility of the cilia. During their motion, the cilia periodically 208 
bend and straighten and the degree of bending is an indication of how flexible the cilia are. By 209 
varying the distance d between the minimum of the parabola and the epithelium (Fig. 4b) we 210 
can vary the bending length and simulate cilia with different flexibilities. In the rest of the 211 
article, we refer at the distance s = Lpcl – d as the bending length. 212 
 213 
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3.2 Dimensionless analysis 214 
Our aim is to determine how the pseudo-diffusivity Dpcl depends on D, f and s. Dimensionless 215 
analysis indicates that the system can be described by only two dimensionless groups. The 216 
Sherwood number is defined as 217 
,
D
D
Sh
pcl=  (7) 
which expresses the ration between the molecular and the apparent diffusivity; and the Péclet 218 
number that, here, works as a dimensionless frequency 219 
.
D
fs
Pe
2
=  (8) 
In our results, therefore, we seek correlations of the type 220 
,KPeSh n=  (9) 
where K and n are two constants to be determined from the simulation data. 221 
In the following sections, we will also use the geometric ratio 222 
,
L
s
pcl
=λ  (10) 
which is not a fundamental dimensionless group, but it will be used, during the discussion, to 223 
highlight some specific aspects that depend on the cilia flexibility. 224 
 225 
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4. Results and discussion 226 
There are two types of parameters required for the simulations: model parameters and 227 
simulation parameters. Model parameters define the SPH, MSM and DMP structures and are 228 
fixed in all the simulations (Appendix B). Simulation parameters such as D, f and s, represent 229 
the operative conditions and are varied as indicated in Table 1. 230 
  231 
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Table 1. List of simulations with diffusivities, frequencies and bending lengths parameters. 232 
Case D [m
2
 s
-1
] f [Hz] s [µm] λ [-] Pe [-] DPCL [m
2
 s
-1
] Sh [-] 
D10v05H3 1 10
-10
 2.5 1.3 0.27 0.04 3.08 10
-11
 0.31 
D10v05H4 1 10
-10
 2.5 1.9 0.38 0.09 3.00 10
-11
 0.30 
D10v05H5 1 10-10 2.5 2.5 0.50 0.16 3.04 10-11 0.30 
D10v05H6 1 10
-10
 2.5 3.1 0.62 0.24 3.14 10
-11
 0.31 
D10v1H3 1 10
-10
 5.0 1.3 0.27 0.09 3.06 10
-11
 0.31 
D10v1H4 1 10
-10
 5.0 1.9 0.38 0.18 2.98 10
-11
 0.30 
D10v1H5 1 10-10 5.0 2.5 0.50 0.32 3.01 10-11 0.30 
D10v1H6 1 10
-10
 5.0 3.1 0.62 0.47 3.14 10
-11
 0.31 
D10v2H3 1 10
-10
 10.0 1.3 0.27 0.18 3.05 10
-11
 0.30 
D10v2H4 1 10
-10
 10.0 1.9 0.38 0.36 2.97 10
-11
 0.30 
D10v2H5 1 10-10 10.0 2.5 0.50 0.63 3.03 10-11 0.30 
D10v2H6 1 10
-10
 10.0 3.1 0.62 0.95 3.21 10
-11
 0.32 
D11v05H3 1 10
-11
 2.5 1.3 0.27 0.45 3.59 10
-12
 0.36 
D11v05H4 1 10
-11
 2.5 1.9 0.38 0.90 3.81 10
-12
 0.38 
D11v05H5 1 10-11 2.5 2.5 0.50 1.58 4.21 10-12 0.42 
D11v05H6 1 10
-11
 2.5 3.1 0.62 2.37 4.46 10
-12
 0.45 
D11v1H3 1 10
-11
 5.0 1.3 0.27 0.89 3.57 10
-12
 0.36 
D11v1H4 1 10
-11
 5.0 1.9 0.38 1.79 3.88 10
-12
 0.39 
D11v1H5 1 10-11 5.0 2.5 0.50 3.16 4.41 10-12 0.44 
D11v1H6 1 10
-11
 5.0 3.1 0.62 4.75 4.92 10
-12
 0.49 
D11v2H3 1 10
-11
 10.0 1.3 0.27 1.79 3.77 10
-12
 0.38 
D11v2H4 1 10
-11
 10.0 1.9 0.38 3.59 4.00 10
-12
 0.40 
D11v2H5 1 10-11 10.0 2.5 0.50 6.32 4.52 10-12 0.45 
D11v2H6 1 10
-11
 10.0 3.1 0.62 9.50 5.21 10
-12
 0.52 
D12v2H3 1 10
-12
 10.0 1.3 0.27 17.88 5.31 10
-13
 0.53 
D12v2H4 1 10
-12
 10.0 1.9 0.38 35.87 5.75 10
-13
 0.58 
D12v2H5 1 10-12 10.0 2.5 0.50 63.15 6.94 10-13 0.69 
D12v2H6 1 10
-12
 10.0 3.1 0.62 94.99 8.58 10
-13
 0.86 
D11v10H3 1 10
-11
 50.0 1.3 0.27 8.94 3.90 10
-12
 0.39 
D11v10H4 1 10
-11
 50.0 1.9 0.38 17.94 4.41 10
-12
 0.44 
D11v10H5 1 10-11 50.0 2.5 0.50 31.58 5.27 10-12 0.53 
D11v10H6 1 10
-11
 50.0 3.1 0.62 47.49 6.33 10
-12
 0.63 
D10v0H3 1 10
-10
 0.0 1.3 0.27 0.00 3.12 10
-11
 0.31 
D10v0H4 1 10
-10
 0.0 1.9 0.38 0.00 3.06 10
-11
 0.31 
D10v0H5 1 10-10 0.0 2.5 0.50 0.00 3.06 10-11 0.31 
D10v0H6 1 10
-10
 0.0 3.1 0.62 0.00 3.17 10
-11
 0.32 
D11v0H3 1 10
-11
 0.0 1.3 0.27 0.00 3.61 10
-12
 0.36 
D11v0H4 1 10
-11
 0.0 1.9 0.38 0.00 3.71 10
-12
 0.37 
D11v0H5 1 10-11 0.0 2.5 0.50 0.00 3.86 10-12 0.39 
D11v0H6 1 10
-11
 0.0 3.1 0.62 0.00 3.99 10
-12
 0.40 
D12v0H3 1 10
-12
 0.0 1.3 0.27 0.00 6.38 10
-13
 0.64 
D12v0H4 1 10
-12
 0.0 1.9 0.38 0.00 6.53 10
-13
 0.65 
D12v0H5 1 10-12 0.0 2.5 0.50 0.00 6.48 10-13 0.65 
D12v0H6 1 10
-12
 0.0 3.1 0.62 0.00 6.32 10
-13
 0.63 
D12v10H3 1 10
-12
 50.0 1.3 0.27 89.38 7.65 10
-13
 0.76 
D12v10H4 1 10
-12
 50.0 1.9 0.38 179.36 9.10 10
-13
 0.91 
D12v10H5 1 10-12 50.0 2.5 0.50 315.76 1.17 10-12 1.17 
D12v10H6 1 10
-12
 50.0 3.1 0.62 474.94 1.67 10
-12
 1.67 
D10v10H3 1 10
-10
 50.0 1.3 0.27 0.89 3.36 10
-11
 0.34 
D10v10H4 1 10
-10
 50.0 1.9 0.38 1.79 3.61 10
-11
 0.36 
D10v10H5 1 10-10 50.0 2.5 0.50 3.16 3.97 10-11 0.40 
D10v10H6 1 10
-10
 50.0 3.1 0.62 4.75 4.22 10
-11
 0.42 
D10v5H3 1 10
-10
 25.0 1.3 0.27 0.45 3.05 10
-11
 0.30 
D10v5H4 1 10
-10
 25.0 1.9 0.38 0.90 3.10 10
-11
 0.31 
D10v5H5 1 10-10 25.0 2.5 0.50 1.58 3.36 10-11 0.34 
D10v5H6 1 10
-10
 25.0 3.1 0.62 2.37 3.61 10
-11
 0.36 
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4.1 Metachronal wave and velocity profiles 233 
The focus of this article is on mass transfer, but, since convection, which depends on the local 234 
velocity pattern, is an important means of mass transfer, in this section, we discuss the typical 235 
velocity profiles obtained from the simulations. Fig. 5a shows the shape of the metachronal 236 
wave obtained in the simulations by using the ‘ghost parabola’ approach. Concerning the 237 
velocity profile (Fig. 5b), the most important feature for convective mass transport is the large 238 
recirculation region occurring where the cilia bend. Higher velocities appear in other regions, 239 
but these are confined within adjacent cilia and, as explained in Section 4.2, they do not 240 
significantly increase mixing in the ciliated-layer. The penetration of the cilia in the mucus 241 
layer is approximately 0.5 µm, which is consistent with values in the literature [22]. The 242 
velocity of the mucus layer in our calculations is around 10 µm s
-1
, which is consistent with 243 
the values reported in the literature (typically ranging from 10 − 60 µm s
-1
 [30]. 244 
18 
 
 245 
Fig. 5. Metachronal wave (a) and velocity profiles (b) for D = 10-11 m2 s-1, f = 10 Hz, s = 2.5 µm. 246 
4.2 Concentration profiles   247 
In order to study the mass transfer within the PCL, we include in our model the equation of 248 
mass conservation of a chemical species A. How this is introduced in the discrete multi-249 
physics model is explained in Appendix D (additional details are given in [13]). A typical 250 
concentration profile is shown in Fig. 6. 251 
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 252 
Fig. 6. Concentration profiles of the chemical species A at different time steps   (D = 10
-11
 m
2
 253 
s
-1
, f = 10 Hz, s = 2.5 µm). 254 
As the metachronal wave moves in the PCL, the bending of the cilia generates an empty 255 
region (free of cilia), called ‘convective region’ in Fig. 6, with characteristic size s, below the 256 
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mucus layer. This region has a large recirculation pattern that increases convective mass 257 
transport. Fig. 6 shows the effect of convection on a typical concentration profile. Initially, we 258 
assume all the drug is fully dissolved in the mucus layer and diffused in the PCL layer from 259 
there. The initial (dimensionless) drug concentration, therefore, is zero in the PCL and 1 in the 260 
mucus layer. The diffusivity of the drug is arbitrarily considered 10 times faster in the mucus 261 
than in the PCL, while the membrane is considered a passive wall with no mass exchange 262 
with the PCL. These boundary conditions allow for an effective calculation of Dpcl as 263 
explained in the next section. 264 
4.3 Calculation of Dpcl  265 
In order to calculate Dpcl, we need the instantaneous concentration profiles in the y-direction, 266 
which are calculated by averaging the concentration over the x-coordinate (Fig. 7a). Mass 267 
transfer in the PCL depends on a combination of diffusion and convection, however, under 268 
certain conditions the dynamics can be considered pseudo-diffusive and an apparent 269 
diffusivity coefficient Dpcl can be used to model mass transport in the ciliated-layer. We also 270 
assume that diffusivity of the drug is substantially larger in the PCL than in the membrane and 271 
we stop our simulation before the drug reaches the membrane. The usefulness of these 272 
assumptions can be understood from Eq. (3) and Fig. 3. From our simulations, we can only 273 
measure the total permeability PTOT of the system. However, we want to calculate the 274 
permeability of the ciliated layer Ppcl. If we arbitrarily set the permeability in the mucus high, 275 
1/Pmu in Eq. (3) can be neglected and, if we stop the simulation before the drug reaches the 276 
membrane, 1/Pme can neglect. Under these circumstances, therefore, PTOT ~Ppcl and, by 277 
measuring PTOT we estimate Ppcl. This is a sort of numerical ‘trick’, it has nothing to do with 278 
the real drug diffusion in the mucus, but allows to correctly estimate Ppcl. Once Ppcl is known, 279 
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realistic values of PTOT can be calculated from Eq. (3) by introducing the actual values of Pme 280 
and Pmu.  281 
Under the assumptions discussed above, the time-dependent concentration profiles in the PCL 282 
follow the formula [31] 283 
,ecc
tD
y
max
pcl4
2
−
=  (11) 
where cmax is the (time-dependent) concentration at y = 0, which depends on the total mass of 284 
drug dissolved in the mucus at the beginning of the simulation and decays with time as t
0.5
. 285 
 286 
 287 
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 288 
Fig. 7. Instantaneous concentration profiles in the y-direction (a), variance of the 289 
concentration versus time (b) and Gaussian fitting of the concentration profile at t = 0.08 s (c) 290 
for the case D = 10
-11
 m
2
 s
-1
, f = 10 Hz, s = 2.5 µm. 291 
 Given Eq. (11), we can calculate the value of Dpcl from the concentration profiles of Fig. 7a. 292 
We compute the (time-dependent) variance σ
2
 of each concentration profile, which, if the 293 
assumptions behind Eq. (11) are valid, should change linearly with time (Fig. 7b). The slope 294 
of Fig. 7b, therefore, gives the numerical value of Dpcl. The pseudo-diffusive hypothesis 295 
implies that the concentration profiles are approximately Gaussian, this is verified in Fig. 7c 296 
for the specific case of D = 10
-11
 m
2
 s
-1
, f = 10 Hz, s = 2.5 µm. The same procedure for the 297 
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calculation of Dpcl is used for all the cases calculated in Table 1 and the results discussed in 298 
the following sections. 299 
4.4 Shielding 300 
Fig. 8 shows how the Sherwood number changes with f and s in the case of D = 10
-11
 m
2
 s
-1
. 301 
Sh < 1 implies that the pseudo-diffusivity in the PCL is lower than the drug’s molecular 302 
diffusivity. This behaviour may look surprising at a first glance since convection can only 303 
increase mixing and, therefore, it is not clear how the pseudo-diffusivity of the PCL can be 304 
lower than the drug’s molecular diffusivity. 305 
The presence of the cilia, however, creates obstacles to the free motion of the drug in the fluid 306 
and, therefore, reduces the apparent mass transfer in the PCL. We have named this 307 
phenomenon shielding and indicate with D0pcl the lowest apparent diffusivity, which occurs at 308 
f → 0 where no convective mixing is present. As f increases, the convective motion enhances 309 
mass transfer and compensates the shielding effect as discussed in the next section 310 
 311 
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 312 
Fig. 8. Sherwood number for D = 10
-11
 m
2
 s
-1
 and various values of f and λ. 313 
4.5 Mass transfer regimes 314 
In Fig. 9 (Sh vs. Pe), we can distinguish three regions. Each of these regions is characterized 315 
by different values of K and n in Eq. (9). We are interested, in particular, in the exponent n 316 
and, therefore, we rewrite Eq. (9) as 317 
.DfsD nnnPCL
−∝ 12  (12) 
Each value of n can be associate to a different mass transfer dynamics. 318 
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 319 
Fig. 9. Sherwood number versus Peclet number for all the simulations in Table 1. 320 
Shielding regime (Pe < 0.2): the beat frequency is low and the shielding effect prevails. The 321 
mass transfer only depends on the diffusivity since the frequency of the cilia beat is very slow, 322 
but the pseudo-diffusivity is only one-third of the molecular diffusivity due to the shielding 323 
effect. The value 0.31 would probably change in three-dimensional simulations, but the 324 
general principle would remain valid. Considering Eq. (12) with n = 0, 325 
,DDpcl ∝  (13) 
which confirms that the pseudo-diffusivity is proportional to the molecular diffusivity. 326 
Diffusive regime (0.2 < Pe < 30): the cilia beat begins to ‘open’ the structure and allow higher 327 
mass transfer in the ciliated-layer. Sh increases, but shielding is still high (Sh < 1). 328 
Considering Eq. (12) with n = 0.1, 329 
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,DfsD ...pcl
901020∝  (14) 
which shows that diffusion is still the main mass transfer mechanics as, in Eq. (14), D has the 330 
highest exponent. 331 
Convective regime (Pe > 0.3): the cilia beat creates significant recirculation regions that 332 
increase Sh. Considering Eq. (12) with n = 0.4, 333 
,DfsD ...pcl
604080∝  (15) 
which indicates that the role of the frequency becomes more significant (its exponent is now 334 
0.4). However, Eq. (15) also suggests that the size of the recirculation region (the exponent of 335 
s is 0.8) is even more important than the actual frequency. 336 
  337 
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5. Conclusions 338 
In this paper, we have used the discrete multi-physics approach to simulate diffusive and 339 
convective mass transfer in boundary layers containing motile cilia. Fluids (mucus and PCL) 340 
and static solid (membrane) are implemented with the Smoothed Particle Hydrodynamics 341 
while flexible cilia are structured with the Mass-Spring model. 342 
Metachronal wave is mimicked by means of “ghost parabola” particles and a mass transfer 343 
algorithm is introduced for modelling concentration diffusion between the mucus and the 344 
membrane through the PCL. 345 
The aim of the present study is to quantify the effects of the ciliated layers on the PCL flow 346 
(convection) and mass transfer. Specifically, we have examined the role of the cilia beat 347 
frequency, the flexibility of the cilia and the initial diffusivity of the mucus. 348 
The aim of the present study is to quantify the effects of the ciliated layers on the PCL flow 349 
(convection) and mass transfer. Specifically, we have examined the role of the cilia beat 350 
frequency, the flexibility of the cilia and the initial diffusivity of the mucus. The model 351 
accounts for several simplifications (2D geometry) and some of the complexities of the 352 
biological system are neglected. In particular, it does not account for microvilli above the 353 
ciliated cells, for discontinuities in the mucus layer and for presence of not-ciliated cells (e.g.  354 
goblet cells). We believe that these factors can potentially affect mass transfer in the ciliated 355 
layer to a certain degree. The physics behind the three mass transfer regimes (e.g. shielding, 356 
diffusive and convective), however, is expected to remain the same. 357 
Mass transfer in the ciliated-layer is hindered by the presence of cilia and the apparent 358 
diffusivity reduces to one-third of the molecular diffusivity. As the frequency of the cilia beat 359 
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increases, recirculation regions appear in the velocity profile. In these regions, mass transfer 360 
increases due to convective mixing. However, the size of the convective regions seems to 361 
affect mass transfer more than the actual frequency. As a consequence of this, we suggest the 362 
possibility that the capacity of the respiratory epithelium to absorb inhaled drugs may be more 363 
strongly correlated with the flexibility of the cilia rather than the frequency of its beat. The 364 
current results could also have implications for our understanding of the mechanisms that lead 365 
to repeated infections and chronic respiratory syndrome in patients with ciliopathies.  In 366 
patients with primary pulmonary ciliary dyskinesia or the more common form of acquired 367 
(secondary) ciliary dyskinesia the altered or completely suppressed function of the cilia 368 
reduces the effectiveness of the mucociliary  “conveyor belt”. As seen in this work, it also has 369 
important implications on the speed with which both drugs and toxic agents can reach the 370 
airway epithelium.     371 
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Appendix A 459 
The DMP version used in this study links SPH and MSM. In this section, we provide a brief 460 
introduction to these techniques and how they are coupled together.  461 
1. Smoothed Particle Hydrodynamics (SPH) 462 
The SPH equations of motion are obtained from the discrete approximations of the 463 
Navier-Stokes equation at a set of points, which can be thought as particles characterized by 464 
their own mass, velocity, pressure and density. The fundamental idea behind this 465 
approximation lies in the identity 466 
,     (A.1) 467 
where f(r) is a generic function defined over the volume V, the vector r is a three-dimensional 468 
point in V and δ(r) is the three-dimensional delta function. In the SPH formalism, the delta 469 
function is approximated by a smoothing Lucy kernel W with characteristic width h 470 
(smoothing length) such that  471 
. (A.2) 472 
This brings to the approximation 473 
     (A.3) 474 
which can be discretised over a series of particles of mass m = ρ(r)dr obtaining 475 
    (A.4) 476 
where mi and ρi are the mass and density of the i
th
 particle, and i ranges over all particles 477 
within the smoothing kernel (i.e. |r−ri| < h). Equation (A.4) represents the discrete 478 
∫∫∫= 'd'-δ'f)f( rr(rrr ))(
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approximation of a generic continuous ﬁeld and can be used to approximate the Navier-Stokes 479 
equation 480 
  (A.5) 481 
where vi is the velocity of particle i, Wi,j means W(rj-ri, h), ∇i denotes the gradient of the 482 
kernel with respect of the coordinate ri, P is the pressure, fi a volumetric body force, and Πi,j 483 
introduces the viscous forces. Various expressions for the tensor Πi,j are available; here we 484 
use (Monaghan and Gingold 1983) 485 
     (A.6) 486 
where α is a parameter (~ 1) used to ensure the stability of the simulation, c is the artificial 487 
sound speed in the liquid and b is a constant introduced to avoid singularities in the case of 488 
very close particles ( ≈ 0.01). The value of α depends on the specific type of simulation; in 489 
this study we use α = 1 as done in previous studies (Ariane et al. 2017a).  490 
In order to close Eq. A.5, an equation of state linking ρ and P is required. In this paper, we 491 
use Tait’s equation 492 
,     (A.7) 493 
where c0 and ρ0 are, respectively the sound speed and density at zero applied stress. 494 
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2. Mass-Spring modelling (MSM) / Coarse-Grained Molecular Dynamics (CGMD) 497 
Molecular dynamics is a form of investigation where the motion and the interaction of a 498 
certain number of computational atoms or molecules are studied. In classical MD simulations 499 
atoms move according to the Newtonian equations of motion 500 
,    (A.8) 501 
where Utot is the total interatomic potential, which can be divided into two main parts: non 502 
bonded and intramolecular. Non bonded forces are usually represented by the so-called 503 
Lennard-Jones potential, while the intramolecular forces are often divided in subgroups e.g. 504 
     (A.9) 505 
Each of these potentials can have different forms. In this study, we use the harmonic bond 506 
potential 507 
      (A.10) 508 
where kb a Hookean coefficient, r0 the equilibrium distance, and the harmonic angle potential 509 
,      (A.11) 510 
where ka is an angular Hookean coefficient and θ0 the equilibrium angle, 511 
Equations (A.9─A.11) are the basis for the ball-and-stick representation of molecules that can 512 
be coarse-grained to model macroscopic solids within the MSM framework. This approach 513 
can be employed to model macroscopic phenomena such as stretching and bending of solids 514 
under the effect of external forces. In the case under investigation, we divide the membrane in 515 
a certain number of notional particles and use the potentials of Eq. A.10 and A.11 to simulate 516 
its deformation. Figure 1 shows how bond and angle potentials are used in the membrane 517 
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model. This component of the DMP has been indicated sometimes as MSM and sometimes as 518 
CGMD. The mathematical formulation is the same: at small scales (e.g. microfluidic 519 
applications) the term CGMD is preferred (Alexiadis 2014), at larger scales the term MSM is 520 
preferred (Alexiadis et al. 2017). 521 
3. Coupling the two models 522 
The interaction between the solid (MSM particles) and the liquid (SPH particles) is defined by 523 
boundary conditions, which relate the behaviour of two adjacent materials at the common 524 
interface. There are three main types of phenomena that must be taken into consideration in 525 
designing these boundary conditions (Müller et al. 2004): no-penetration, no-slip and 526 
continuity of stresses. In continuum mechanics, these conditions are often represented as 527 
 (no – penetration),     (A.12) 528 
 (no – slip)      (A.13) 529 
and 530 
 (continuity of stresses)    (A.14) 531 
where n is the normal to the boundary, u the displacement of the solid, v the velocity of the 532 
liquid, σs the stresses in the solid and σf in the fluid.  533 
In the particle framework, various no-penetration methods can be implemented (Ferrand et al. 534 
2013) and an additional central force of the Lennard-Jones type is often used 535 
,    (A.15) 536 
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where r* represents the repulsive radius of the particle, and n1 and n2 are usually set to 4 and 537 
2, although also the original 12-6 Lennard-Jones values are sometimes used. The constant K is 538 
chosen on the basis of a characteristic velocity of the flow. 539 
Concerning the “ghost parabola”, we use a softer repulsion potential based on a cosines form 540 
that only push apart overlapping cilia particles 541 
      (A.16) 542 
With Ks a constant chosen arbitrarily according to the simulations. 543 
The no-slip condition models the friction between the solid and the fluid. In finite-element 544 
numerical methods it is enforced by imposing that the two materials have the same velocity at 545 
the interface. The advantage of using a particle-particle representation is that, once both the 546 
no-penetration and no-slip boundary condition are enforced, the continuity of stress is 547 
automatically satisfied by the equation of motion (A.5). 548 
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Appendix B 559 
There are two types of parameter required for the simulations: model parameters and 560 
simulation parameters. Table B.1 list the numerical values used in the model parameters 561 
(simulation parameters are discussed in section 2 of the manuscript). 562 
Table B.1. Model parameters used in the simulations. 563 
SPH (eqs. A.5−A.7)  
Parameter Value 
Number of membrane particles (10 layers) 3270 
Number of PCL particles 19788  
Number of mucus particles Nmucus 7050 
Number of cilium particles (36 cilia) 2592 (72 particles/cilium) 
Number of Ghost parabola particles (1 layer) 343 
Mass of each particle 4.3.·10
-12
 kg 
Initial distance among particles ∆r 6.6·10
-8
 m 
Smoothing length h 1.98·10
-7
 m 
Artificial sound speed c0 0.25 m s
-1
 
Density of PCL ρ  1000 kg m
-3
 
Density of mucus ρ 1000 kg m
-3
 
Dynamic viscosity of PCL µ 1 10
-3
 Pa s 
Dynamic viscosity of mucus µ 20 Pa s 
Time step ∆t 10
-8
 s 
MSM (eqs. A.8-A.11) 
Parameter Value 
Angular coefficient ka  1.0 10
-12
 J 
Hookian coefficient kb  20 J m
-2
 
Equilibrium distance r0 6.6·10
-8
 m 
BOUNDARIES (Eq. A12-A.15) 
Constant K 5 10
-16
 J 
Constant Ks 8 10
-15
 J 
Repulsive radius r* 1.65 10
-7 
m 
The viscoelastic properties of the mucus are discussed in Appendix C. 564 
 565 
  566 
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Appendix C 567 
To model viscoelastic fluids in discrete multi-physics, we can implement the viscosity via 568 
SPH forces (see Appendix A) and add the elasticity as an equivalent attractive force 569 
 (C.1) 
where kb is the Hookean bending coefficient of Eq. A.10, E the Young modulus of mucus, A0 570 
the sectional area and Lmu the thickness of the mucus layer. 571 
Moreover, since the elastic force is shared by all the mucus particles k*=kb/Nmucus, where 572 
Nmucus is the number of computational particles used for the mucus layer. Mucus is a 573 
viscoelastic fluid and not a viscoelastic solid, consequently, we cannot use actual Hookean 574 
springs that would prevent relative motion of the fluid particles. Therefore, we approximate 575 
locally the harmonic potential with a Lennard Jones form with the minimum in the same 576 
position. This implies that the second derivative of both potentials should be the same at r0 577 
e.g. 578 
 (C.2) 
which gives ε = k*/72. 579 
In our case, E = 10 Pa ; Nmucus = 7050, Lme = 0.6·10
-6
 m and, therefore, ε = 1·10
-6 
J. This 580 
produces a Maxwell viscoelastic material with µ = 20 Pa s and E = 10 Pa. 581 
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